Literature DB >> 28728659

A Systematic Review of Infective Endocarditis in Patients With Bovine Jugular Vein Valves Compared With Other Valve Types.

Ashutosh Sharma1, Anita T Cote2, Martin C K Hosking3, Kevin C Harris4.   

Abstract

OBJECTIVES: The aim of this study was to systematically evaluate the incidence of infective endocarditis (IE) in right ventricle-to-pulmonary artery conduits and valves, comparing bovine jugular vein (BJV) valves with all others.
BACKGROUND: Recent evidence suggests that the incidence of IE is higher in patients with congenital heart disease who have undergone implantation of BJV valves in the pulmonary position compared with other valves.
METHODS: Systematic searches of published research were conducted using electronic databases (MEDLINE, Embase, and CINAHL) and citations cross-referenced current to April 2016. Included studies met the following criteria: patients had undergone right ventricle-to-pulmonary artery conduit or percutaneous pulmonary valve implantation, and investigators reported on the type of conduit or valve implanted, method of intervention (surgery or catheter based), IE incidence, and follow-up time.
RESULTS: Fifty studies (Levels of Evidence: 2 to 4) were identified involving 7,063 patients. The median cumulative incidence of IE was higher for BJV compared with other valves (5.4% vs. 1.2%; p < 0.0001) during a median follow-up period of 24.0 and 35.5 months, respectively (p = 0.03). For patients with BJV valves, the incidence of IE was not different between surgical and catheter-based valve implantation (p = 0.83).
CONCLUSIONS: There was a higher incidence of endocarditis with BJV valves than other types of right ventricle-to-pulmonary artery conduits. There was no difference in the incidence of endocarditis between catheter-based bovine valves and surgically implanted bovine valves, suggesting that the substrate for future infection is related to the tissue rather than the method of implantation.
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Contegra; Melody valve; congenital heart disease; infective endocarditis

Mesh:

Year:  2017        PMID: 28728659     DOI: 10.1016/j.jcin.2017.04.025

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  11 in total

Review 1.  Infective endocarditis in paediatric population.

Authors:  Loay Eleyan; Ameer Ahmed Khan; Gledisa Musollari; Ashwini Suresh Chandiramani; Simran Shaikh; Ahmad Salha; Abdulla Tarmahomed; Amer Harky
Journal:  Eur J Pediatr       Date:  2021-04-14       Impact factor: 3.183

2.  Time-trend population analysis of the clinical and epidemiologic effect on pediatric infective endocarditis after change of antibiotic prophylaxis guidelines.

Authors:  Walter Knirsch; Stefanie Katharina Schuler; Martin Christmann; Roland Weber
Journal:  Infection       Date:  2020-04-30       Impact factor: 3.553

3.  Pulmonary valve endocarditis in adults with congenital heart disease: the role of echocardiography in a case series.

Authors:  Flavia Fusco; Giancarlo Scognamiglio; Anna Correra; Assunta Merola; Diego Colonna; Michela Palma; Emanuele Romeo; Berardo Sarubbi
Journal:  Eur Heart J Case Rep       Date:  2020-09-19

4.  Mid-term outcomes of Contegra implantation for the reconstruction of the right ventricular outflow tract to proximal branch pulmonary arteries: Japan multicentre study.

Authors:  Takaya Hoashi; Hajime Ichikawa; Keiichi Hirose; Naohiro Horio; Takahisa Sakurai; Hironori Matsuhisa; Yoshihiro Ohsima; Hajime Sakurai; Shingo Kasahara; Kisaburo Sakamoto
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-07-26

Review 5.  Percutaneous Pulmonary Valve Implantation: Current Status and Future Perspectives.

Authors:  Bart W Driesen; Evangeline G Warmerdam; Gert-Jan Sieswerda; Folkert J Meijboom; Mirella M C Molenschot; Pieter A Doevendans; Gregor J Krings; Arie P J van Dijk; Michiel Voskuil
Journal:  Curr Cardiol Rev       Date:  2019

6.  Nationwide Registry-Based Analysis of Infective Endocarditis Risk After Pulmonary Valve Replacement.

Authors:  Clara Stammnitz; Dörte Huscher; Ulrike M M Bauer; Aleksandra Urban; Johannes Nordmeyer; Stephan Schubert; Joachim Photiadis; Felix Berger; Sabine Klaassen
Journal:  J Am Heart Assoc       Date:  2022-02-18       Impact factor: 5.501

Review 7.  Current development of bovine jugular vein conduit for right ventricular outflow tract reconstruction.

Authors:  Chenggang Li; Bo Xie; Ruizhe Tan; Lijin Liang; Zhaoxiang Peng; Qi Chen
Journal:  Front Bioeng Biotechnol       Date:  2022-08-04

8.  Outcomes after right ventricular outflow tract reconstruction with valve substitutes: A systematic review and meta-analysis.

Authors:  Xu Wang; Wouter Bakhuis; Kevin M Veen; Ad J J C Bogers; Jonathan R G Etnel; Carlijn C E M van Der Ven; Jolien W Roos-Hesselink; Eleni-Rosalina Andrinopoulou; Johanna J M Takkenberg
Journal:  Front Cardiovasc Med       Date:  2022-09-07

9.  Medium long-term follow-up outcomes of BalMedic® bovine pericardial bioprosthetic valve in the mitral position.

Authors:  Sumin Yang; Haoyu Hu; Minghao Lin; Naiyan Gan
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 2.895

10.  Infective Endocarditis After Melody Valve Implantation in the Pulmonary Position: A Systematic Review.

Authors:  Mohammad Abdelghani; Martina Nassif; Nico A Blom; Martijn S Van Mourik; Bart Straver; David R Koolbergen; Jolanda Kluin; Jan G Tijssen; Barbara J M Mulder; Berto J Bouma; Robbert J de Winter
Journal:  J Am Heart Assoc       Date:  2018-06-22       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.